AJ

Ashish Jayant Jumrani

Active Director Designated Partner DIN 08769810
DIN 08769810 First appointment Jul 2020 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashish Jayant Jumrani

Data last updated:

Ashish Jayant Jumrani is a Designated Partner at Jaayu Pharma Llp (since 2020). The company operates in Chemicals.

DIN 08769810
Primary Designation Designated Partner
Industry Chemicals
First Appointment 18 Jul 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jaayu Pharma Llp AAS-9431
Designated Partner18 Jul 20202020Active

Board colleagues of Ashish Jayant Jumrani

NameDINCompanyDesignation
Jay Hemant Mahabal08798825Jaayu Pharma LlpDesignated Partner
Shubham Suresh Khot08798826Jaayu Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Jaayu Pharma Llp
Premium access

Shareholding and investment profile for Ashish Jayant Jumrani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashish Jayant Jumrani

Ashish Jayant Jumrani currently holds 1 directorship: Jaayu Pharma Llp (Designated Partner, since 18 Jul 2020).

Ashish Jayant Jumrani was first appointed on 18 Jul 2020 as Designated Partner at Jaayu Pharma Llp.

The current boards of Ashish Jayant Jumrani's companies include Jay Hemant Mahabal (Jaayu Pharma Llp), Shubham Suresh Khot (Jaayu Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available